Package 11673-070-01

Brand: headache relief

Generic: acetaminophen-aspirin-caffeine
NDC Package

Package Facts

Identity

Package NDC 11673-070-01
Digits Only 1167307001
Product NDC 11673-070
Description

100 TABLET, COATED in 1 BOTTLE (11673-070-01)

Marketing

Marketing Status
Marketed Since 2020-02-04
Brand headache relief
Generic acetaminophen-aspirin-caffeine
Sample Package No

Linked Drug Pages (1)

Raw FDA Data

View complete raw FDA NDC JSON payload
{"route": ["ORAL"], "spl_id": "21584bc6-a28f-14ee-e063-6394a90a5ce6", "openfda": {"nui": ["N0000000160", "N0000008836", "M0001335", "N0000175722", "N0000175578", "N0000008832", "N0000175739", "N0000175729", "N0000175790", "M0023046"], "unii": ["362O9ITL9D", "R16CO5Y76E", "3G6A5W338E"], "rxcui": ["308297"], "spl_set_id": ["8e953cef-135e-f1aa-e053-2995a90aaa8b"], "pharm_class_cs": ["Anti-Inflammatory Agents, Non-Steroidal [CS]", "Xanthines [CS]"], "pharm_class_pe": ["Decreased Prostaglandin Production [PE]", "Decreased Platelet Aggregation [PE]", "Central Nervous System Stimulation [PE]"], "pharm_class_epc": ["Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Central Nervous System Stimulant [EPC]", "Methylxanthine [EPC]"], "pharm_class_moa": ["Cyclooxygenase Inhibitors [MoA]"], "manufacturer_name": ["TARGET CORPORATION"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "100 TABLET, COATED in 1 BOTTLE (11673-070-01)", "package_ndc": "11673-070-01", "marketing_start_date": "20200204"}, {"sample": false, "description": "275 TABLET, COATED in 1 BOTTLE (11673-070-72)", "package_ndc": "11673-070-72", "marketing_start_date": "20200204"}], "brand_name": "HEADACHE RELIEF", "product_id": "11673-070_21584bc6-a28f-14ee-e063-6394a90a5ce6", "dosage_form": "TABLET, COATED", "pharm_class": ["Anti-Inflammatory Agents", "Non-Steroidal [CS]", "Central Nervous System Stimulant [EPC]", "Central Nervous System Stimulation [PE]", "Cyclooxygenase Inhibitors [MoA]", "Decreased Platelet Aggregation [PE]", "Decreased Prostaglandin Production [PE]", "Methylxanthine [EPC]", "Nonsteroidal Anti-inflammatory Drug [EPC]", "Platelet Aggregation Inhibitor [EPC]", "Xanthines [CS]"], "product_ndc": "11673-070", "generic_name": "ACETAMINOPHEN-ASPIRIN-CAFFEINE", "labeler_name": "TARGET CORPORATION", "product_type": "HUMAN OTC DRUG", "brand_name_base": "HEADACHE RELIEF", "active_ingredients": [{"name": "ACETAMINOPHEN", "strength": "250 mg/1"}, {"name": "ASPIRIN", "strength": "250 mg/1"}, {"name": "CAFFEINE", "strength": "65 mg/1"}], "application_number": "M013", "marketing_category": "OTC MONOGRAPH DRUG", "marketing_start_date": "20191004", "listing_expiration_date": "20261231"}